Vanguard Group’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

Vanguard Group’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-42,253	Closed	-$266K	–	3861
2013 Q2	$266K	Buy	+42,253	New	+$253K	﹤0.01%	3601

Other funds holding PBTH

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Vanguard Group's PBTH Position: Q3 2013 in Review

Vanguard Group sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 42,253 shares — an estimated $266K sold.

Vanguard Group first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $266K in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

Vanguard Group reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
Vanguard Group sold 42,253 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $266K.
Vanguard Group first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
Vanguard Group's PROLOR Biotech, Inc. Common Stock position peaked at $266K in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on Vanguard Group's 13F filing for Q3 2013, filed 7 Nov 2013.